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Increase in high molecular weight adiponectin by bariatric
surgery-induced weight loss
Abstract
Aim: To determine the changes in adiponectin multimers upon marked weight loss.
Methods: Plasma samples were obtained preoperatively and 3, 6, 12 and 24 months after surgery from
12 obese subjects undergoing weight loss-inducing bariatric surgery. Seven non-operated obese subjects
served as controls. Plasma levels of adiponectin multimers were determined by protease digestion and
Enzyme-Linked ImmunoSorbent Assay (ELISA) detection. In addition, adiponectin multimers were
assessed by western blotting.
Results: In patients with weight loss after surgery but not in controls, total adiponectin and high
molecular weight (HMW) adiponectin steadily increased during the observation period. Twenty-four
months after surgery, the increase in total and HMW adiponectin was 2.2 ± 0.46 and 1.4 ± 0.3 μg/ml,
respectively. In contrast, plasma concentrations of middle and low molecular weight adiponectin
remained unchanged.
Conclusions: The increase in plasma adiponectin levels observed 24 months after bariatric surgery
depended on continuous weight loss and was completely attributable to the HMW complex.
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Abstract 
Aim To determine the changes in adiponectin multimers upon marked weight loss. 
Methods Plasma samples were obtained pre-operatively and 3, 6, 12 and 24 months 
after surgery from twelve obese subjects undergoing weight loss-inducing bariatric 
surgery. Seven non operated obese subjects served as controls. Plasma levels of 
adiponectin multimers were determined by protease digestion and ELISA detection. 
In addition, adiponectin multimers were assessed by western blotting. 
Results In patients with weight loss after surgery but not in controls, total adiponectin 
and high molecular weight (HMW) adiponectin steadily increased during the 
observation period. 24 months after surgery the increase in total and HMW 
adiponectin was 2.2 ± 0.46 µg/mL, and 1.4 ± 0.3 µg/mL respectively. In contrast, 
plasma concentrations of middle and low molecular weight adiponectin remained 
unchanged.  
Conclusions The increase in plasma adiponectin levels observed 24 months after 
bariatric surgery depended on continuous weight loss and was completely 
attributable to the HMW complex. 
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Introduction 
Adiponectin is an adipocyte-specific protein with insulin-sensitizing, anti-inflammatory 
and anti-atherogenic properties (1). Circulating levels of adiponectin are negatively 
correlated with the degree of obesity and with insulin resistance.  
The 30 kD protein adiponectin circulates mainly as three different oligomeric 
complexes including trimers, hexamers and high molecular weight (HMW) structures 
of approximately 360 kD (2). The HMW level correlates particularly well with insulin 
sensitivity and is associated with the presence of the metabolic syndrome (3-5). 
Moderate weight loss without surgical intervention has been reported to increase 
total adiponectin levels and the HMW / total adiponectin ratio (6; 7). In contrast, other 
authors found no effects of weight loss on either total adiponectin levels (8; 9) or 
multimeric complexes (10). Marked weight loss by Roux-en-Y gastric bypass 
increased total adiponectin (11) and, especially, HMW multimers (12).  
Originally, adiponectin multimers had to be assessed by laborious gradient 
sedimentation followed by immunodetection (2; 13). The procedure has been 
simplified by Waki et al who who visualized adiponectin multimers by non-reducing, 
non-denaturing SDS-PAGE and western blot (14). However, there is currently no 
generally recognized, uniform definition of the size of the multimeric forms circulating 
in humans and animals. A recently commercialized quantitative assay uses 
proteases that specifically degrade middle molecular weight (MMW) and low 
molecular weight (LMW), but not HMW multimeric structures of an estimated size of 
669 kD (15). The non-degraded adiponectin is subsequently quantified by ELISA. 
Herein, we aimed to determine adiponectin multimers in overweight patients before 
and during a 24 month follow-up after weight loss-inducing surgery (i.e., Roux-en-Y 
gastric bypass, gastric banding) as compared to obese control patients without 
surgery and weight loss. 
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Materials and Methods 
Study subjects 
Nineteen patients with morbid obesity (BMI > 37 kg/m2) were evaluated for weight 
loss-inducing surgery. In seven patients the treatment was laparoscopically placed 
adjustable gastric banding (Swedish gastric banding; Obtech Medical AG, Baar, 
Switzerland) and in five subjects the treatment was gastric bypass (proximal Roux-
en-Y gastric bypass, open procedure, Roux limb 75 cm). Seven obese subjects 
served as controls. The characteristics of the study population have been described 
elsewhere (16; 17). The study has been approved by the local ethical committee and 
all patients gave written informed consent to participate. 
 
Adiponectin multimer measurement 
Plasma samples were collected in the fasting state before surgery and at follow-up 
visits, processed within 30 min and stored at -70 °C. Total, LMW, MMW and HMW 
adiponectin concentrations were determined with a kit according to the 
manufacturer’s instructions (EK-MADP Multimeric Adiponectin ELISA Kit, 
BÜHLMANN Laboratories AG, Schönenbuch, Switzerland).  
 
Western blot 
Adiponectin complexes were detected by western blot as described previously by 
Waki et al (14) with modifications. Briefly, 1.5 µl plasma samples were 
electrophoresed without reducing agents on 4-15% SDS-PAGE gels (Ready GelTM, 
BioRad, Hercules, CA). After protein transfer, the nitrocellulose membranes (Optitran 
BA-S 85, Whatman®, Dassel, Germany) were blocked in PBS containing 10% low fat 
milk and exposed to rabbit anti-adiponectin (Santa Cruz Biotechnology Inc., 
Heidelberg, Germany). Membranes were incubated with horse radish peroxidase–
conjugated anti rabbit (1:10’000; Jackson ImmunoResearch Europe Ltd., Suffolk, 
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UK), subjected to ECL detection reagent (ImmunStarTM, BioRad, Hercules, CA) and 
exposed to x-ray film (Kodak BioMax, Rochester, NY).  
 
Statistical analysis 
Data are shown as means ± SEM. Two groups of data were compared by unpaired 
Student’s t tests. A p value < 0.05 was considered statistically significant.  
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Results 
Baseline characteristics 
Pre-operative characteristics of the study group (15 females, 4 males) are shown in 
Table 1. Before surgery, there were no significant differences between the three 
groups (i.e., controls, bypass, banding) regarding age, BMI, total adiponectin, HMW 
adiponectin, MMW adiponectin, LMW adiponectin, and SA ratio.  
Patients without surgery had no significant change in BMI, total adiponectin, HMW, 
MMW, LMW and SA ratio during the 24 month follow up period (Fig. 1A-D). Because 
of the relatively small number of subjects, patients with gastric banding or bypass 
were grouped for the presentation of results. Surgery induced a drop in BMI (not 
shown). In contrast to controls subjects, time-dependent increases in total 
adiponectin (p = 0.0016) and HMW (p = 0.003) adiponectin were observed in patients 
who underwent surgery. 24 months after surgery the increase in total and HMW 
adiponectin was 2.2 ± 0.46 µg/mL (p < 0.05), and 1.4 ± 0.3 µg/mL (p < 0.01) 
respectively (Fig. 1A). The plasma concentrations of MMW adiponectin (p = 0.08) 
and LMW (p = 0.08) adiponectin remained unchanged in both controls and patients 
with surgical intervention (Fig. 1C-D). 
Western blot analysis of plasma samples revealed several bands of distinct sizes 
(Fig. 1E): Heat > 55 ˚C and reducing agents (i.e., dithioerythritol) led to 
disappearance of the signals > 60 kD (not shown). In the two representative subjects 
shown in Fig. 1E, weight loss was associated with increasing intensity of the highest 
adiponectin signal.  
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Discussion 
The present data are the first to assess plasma adiponectin multimer levels by two 
independent methods (i.e., protease digestion - ELISA; western blot) over a two year 
follow-up period after weight loss-inducing bariatric surgery. The increase in 
adiponectin was mainly attributable to the HMW complex and depended on sustained 
weight loss over the whole 24 months follow-up period.  
Our data are in agreement with several reports showing increased total adiponectin 
after different interventions leading to marked weight loss (6; 7; 11; 18; 19). The 
ELISA used in the present report has been previously used to demonstrate an 
increase in HMW adiponectin 12 months after gastric bypass surgery in obese 
women (12).  
Several authors failed to detect increases in serum adiponectin concentrations after 
weight loss (8-10; 20). These data, however were obtained after follow-up periods of 
4 months or less, and weight loss achieved by lifestyle intervention was relatively 
modest. In contrast, the above-cited data pointing to adiponectin-increasing effects of 
weight loss were obtained after at least 3 months. Moreover, serum adiponectin 
levels increased after interventions which were often surgical and the resulting weight 
loss was markedly more pronounced as compared to lifestyle interventions. Thus, the 
discrepancies regarding weight loss-regulated adiponectin serum levels in the 
literature may be explained by the different lengths of observation or by the 
magnitude of weight loss. The present long-term data obtained after up to 24 months 
of observation are consistent with this concept. 
The bands we detected by western blot in the range between ~100 and ~300 kD 
corresponded roughly to the pattern as shown by Waki et al (14). However, the 
largest complex we detected presumably corresponded to the HMW complex 
migrating at 669kD described by Ebinuma et al (15). In accordance with our data 
obtained by ELISA, this signal was increased in two patients with pronounced weight 
loss, whereas the other bands remained virtually unchanged. In the report by Abbasi 
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et al this signal was not present in the western blot analysis (10). This may possibly 
explain the absence of weight loss-induced adiponectin. 
In summary, the present data show that the obesity-associated increase in plasma 
adiponectin is predominantly attributable to elevated levels of the HMW complex. 
Further studies are needed to clarify the mechanisms regulating the circulating levels 
of adiponectin complexes and their specific roles in translating obesity into metabolic 
diseases. 
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Legends to figures 
 
Figure 1 Plasma levels of adiponectin multimers after bariatric surgery.  
Plasma samples were obtained from obese subjects at baseline and 3, 6, 12, 24 and 
48 months after weight loss-inducing bariatric surgery (n = 12). Samples were also 
obtained from control subjects not undergoing surgery (n=7). Adiponectin multimers 
were quantified in all samples by a protease digestion and ELISA-based assay (A-D). 
In addition adiponectin multimers were semi-quantitatively detected by western blot 
in non denatured samples of two representative subjects (E). Results are presented 
as means ± SEM. * indicates p < 0.05 compared to controls at the respective time 
point. – indicates negative controls performed without primary anti-adiponectin 
antibody. 
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Table 1 Pre-operative plasma concentrations of adiponectin multimers 
 
 Controls (n = 7) Banding (n = 7) Bypass (n =5) 
months after 
 surgery 
0      24 0 24 0 24
Age 
[years] 
49.9 ± 6.9  43.8 ± 9.8    41.1 ± 7.3
BMI 
[kg/m2] 
41.1 ± 2.6 41.0 ± 3.4 43.6 ± 4.4 33.2 ± 6.9 41.7 ± 2.8 33.2 ± 4.7 
Total ADIP 
[µg/mL] 
5.8 ± 1.53 5.5 ± 1.1 
NS 
2.6 ± 0.43 4.1 ± 0.87 
p = 0.0093
4.8 ± 0.99 7.7 ± 1.5 
p = 0.0062
HMW 
[µg/mL] 
2.45 ± 0.87 
 
2.17 ± 0.58 
NS 
0.85 ± 0.23 1.7 ±  0.49
p = 0.0093
2.2 ± 0.83 4.1 ± 0.97 
p = 0.0079
HMW/ADIP 
SA 
0.34 ± 0.05 0.34 ± 0.03 
NS 
0.31 ± 0.04 0.40 ± 0.05
p = 0.0026
0.46 ± 0.07 0.5 ± 0.04 
NS 
MMW 
[µg/mL] 
1.59 ± 0.32 1.62 ± 0.33 
NS 
0.95 ± 0.13 0.92 ± 0.15
NS 
1.2 ± 0.12 
NS 
1.3 ± 0.40 
NS 
LMW 
[µg/mL] 
1.81 ± 0.39 1.76 ± 0.37 
NS 
0.90 ± 0.12 1.2 ± 0.30 
NS 
1.3 ± 0.24 
 
1.8 ± 0.48 
NS 
 
Data are means ± SEM, all pre-operative parameters were not significantly different between the controls and the two surgery groups 
(i.e., banding, bypass). Pre-operative concentrations of total adiponectin and HMW adiponectin were higher in females as compared 
to males. 
